Emma Louise Woods
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emma Louise Woods has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Jordanna Dally
Cardiff University, Cardiff, United Kingdom, UK
5 shared publications - Ryan Moseley
Oral and Biomedical Sciences, School of Dentistry, Cardiff University, Cardiff CF14 4XY, UK
5 shared publications - Adam Christopher Midgley
Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
4 shared publications - Robert Steadman
Cardiff University, Cardiff, United Kingdom, UK
4 shared publications - Albert Suryaprawira
Disease Mechanisms Group, Oral and Biomedical Sciences, School of Dentistry, College of Biomedical and Life Sciences, Cardiff University, Cardiff CF14 4XY, UK
1 shared publication Aled O. Phillips
Wales Kidney Research Unit, Systems Immunity University Research Institute, Division of Infection and Immunity, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by MDPI AG in Preprints.org
Epoxytigliane Modulation of Dermal Fibroblast-Myofibroblast Wound Healing Responses Mediate Enhanced Anti-Scarring Properties via Classical Protein Kinase C Activation
Epoxytiglianes are a novel class of diterpene esters. Prototype epoxytigliane, EBC-46 (tigilanol tiglate), possesses potent anti-cancer properties and is being developed as a human/veterinary tumor treatment. EBC-46 mediates such tumoricidal effects in part via classical protein kinase C (PKC) activation; and consistently promotes desirable wound healing outcomes at treated tumor sites, including minimal scarring. As the mechanisms underlying these anti-scarring responses are poorly understood, we investigated the effects of 1.51 nM-151 µM EBC-46 and analogue (EBC-211) on scarring responses in dermal fibroblasts and myofibroblasts. EBC-46 and EBC-211 significantly inhibited G1/S and S/G2 cell cycle transitions and fibroblast proliferation; with limited effects on migration. Both epoxytiglianes induced concentration-dependent inhibitory effects on transforming growth factor-β1 (TGF-β1)-driven fibroblast-myofibroblast differentiation at 151 nM EBC-46 and 15.1 µM EBC-211, with significantly reduced α-smooth muscle actin (αSMA) gene (ACTA2) expression and stress fiber formation. Epoxytiglianes were shown to modulate myofibroblast gene expression profiles associated with the cytoskeleton, extracellular matrix and proteolytic remodeling, in favor of scar resolution. PKC inhibitors (bisindolylmaleimide-1, GÖ6976) both attenuated epoxytigliane inhibition of myofibroblast formation. By identifying how epoxytiglianes induce minimal scarring outcomes in treated skin, we highlight the potential of epoxytiglianes as novel therapeutics for clinical situations associated with excessive dermal scarring.
- 16 November 2026
- Published by MDPI AG in Preprints.org
Open AccessEpoxytigliane Modulation of Dermal Fibroblast-Myofibroblast Wound Healing Responses Mediate Enhanced Anti-Scarring Properties via Classical Protein Kinase C Activation
Epoxytiglianes are a novel class of diterpene esters. Prototype epoxytigliane, EBC-46 (tigilanol tiglate), possesses potent anti-cancer properties and is being developed as a human/veterinary tumor treatment. EBC-46 mediates such tumoricidal effects in part via classical protein kinase C (PKC) activation; and consistently promotes desirable wound healing outcomes at treated tumor sites, including minimal scarring. As the mechanisms underlying these anti-scarring responses are poorly understood, we investigated the effects of 1.51 nM-151 µM EBC-46 and analogue (EBC-211) on scarring responses in dermal fibroblasts and myofibroblasts. EBC-46 and EBC-211 significantly inhibited G1/S and S/G2 cell cycle transitions and fibroblast proliferation; with limited effects on migration. Both epoxytiglianes induced concentration-dependent inhibitory effects on transforming growth factor-β1 (TGF-β1)-driven fibroblast-myofibroblast differentiation at 151 nM EBC-46 and 15.1 µM EBC-211, with significantly reduced α-smooth muscle actin (αSMA) gene (ACTA2) expression and stress fiber formation. Epoxytiglianes were shown to modulate myofibroblast gene expression profiles associated with the cytoskeleton, extracellular matrix and proteolytic remodeling, in favor of scar resolution. PKC inhibitors (bisindolylmaleimide-1, GÖ6976) both attenuated epoxytigliane inhibition of myofibroblast formation. By identifying how epoxytiglianes induce minimal scarring outcomes in treated skin, we highlight the potential of epoxytiglianes as novel therapeutics for clinical situations associated with excessive dermal scarring.
- Open Access
- 14 June 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 450 (2) , 114646
Dysfunctional pericellular hyaluronan deposition contributes to attenuated CD44/EGFR co-localization and impaired myofibroblast differentiation in chronic wound fibroblasts
- 14 June 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 450 (2) , 114646
Open AccessDysfunctional pericellular hyaluronan deposition contributes to attenuated CD44/EGFR co-localization and impaired myofibroblast differentiation in chronic wound fibroblasts
- Open Access
- 30 June 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (7) , 1374
Role of Enzymic Antioxidants in Mediating Oxidative Stress and Contrasting Wound Healing Capabilities in Oral Mucosal/Skin Fibroblasts and Tissues
Unlike skin, oral mucosal wounds are characterized by rapid healing and minimal scarring, attributable to the “enhanced” healing properties of oral mucosal fibroblasts (OMFs). As oxidative stress is increasingly implicated in regulating wound healing outcomes, this study compared oxidative stress biomarker and enzymic antioxidant profiles between patient-matched oral mucosal/skin tissues and OMFs/skin fibroblasts (SFs) to determine whether superior oral mucosal antioxidant capabilities and reduced oxidative stress contributed to these preferential healing properties. Oral mucosa and skin exhibited similar patterns of oxidative protein damage and lipid peroxidation, localized within the lamina propria/dermis and oral/skin epithelia, respectively. SOD1, SOD2, SOD3 and catalase were primarily localized within epithelial tissues overall. However, SOD3 was also widespread within the lamina propria localized to OMFs, vasculature and the extracellular matrix. OMFs were further identified as being more resistant to reactive oxygen species (ROS) generation and oxidative DNA/protein damage than SFs. Despite histological evaluation suggesting that oral mucosa possessed higher SOD3 expression, this was not fully substantiated for all OMFs examined due to inter-patient donor variability. Such findings suggest that enzymic antioxidants have limited roles in mediating privileged wound healing responses in OMFs, implying that other non-enzymic antioxidants could be involved in protecting OMFs from oxidative stress overall.
- 30 June 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (7) , 1374
Open AccessRole of Enzymic Antioxidants in Mediating Oxidative Stress and Contrasting Wound Healing Capabilities in Oral Mucosal/Skin Fibroblasts and Tissues
Unlike skin, oral mucosal wounds are characterized by rapid healing and minimal scarring, attributable to the “enhanced” healing properties of oral mucosal fibroblasts (OMFs). As oxidative stress is increasingly implicated in regulating wound healing outcomes, this study compared oxidative stress biomarker and enzymic antioxidant profiles between patient-matched oral mucosal/skin tissues and OMFs/skin fibroblasts (SFs) to determine whether superior oral mucosal antioxidant capabilities and reduced oxidative stress contributed to these preferential healing properties. Oral mucosa and skin exhibited similar patterns of oxidative protein damage and lipid peroxidation, localized within the lamina propria/dermis and oral/skin epithelia, respectively. SOD1, SOD2, SOD3 and catalase were primarily localized within epithelial tissues overall. However, SOD3 was also widespread within the lamina propria localized to OMFs, vasculature and the extracellular matrix. OMFs were further identified as being more resistant to reactive oxygen species (ROS) generation and oxidative DNA/protein damage than SFs. Despite histological evaluation suggesting that oral mucosa possessed higher SOD3 expression, this was not fully substantiated for all OMFs examined due to inter-patient donor variability. Such findings suggest that enzymic antioxidants have limited roles in mediating privileged wound healing responses in OMFs, implying that other non-enzymic antioxidants could be involved in protecting OMFs from oxidative stress overall.
- Open Access
- 1 September 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (3) , 100987
CD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-β1
- 1 September 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (3) , 100987
Open AccessCD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-β1
- Top Cited PapersOpen Access
- 23 July 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (8) , 1095
Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis
Myofibroblasts are contractile, α-smooth muscle actin-positive cells with multiple roles in pathophysiological processes. Myofibroblasts mediate wound contractions, but their persistent presence in tissues is central to driving fibrosis, making them attractive cell targets for the development of therapeutic treatments. However, due to shared cellular markers with several other phenotypes, the specific targeting of myofibroblasts has long presented a scientific and clinical challenge. In recent years, myofibroblasts have drawn much attention among scientific research communities from multiple disciplines and specialisations. As further research uncovers the characterisations of myofibroblast formation, function, and regulation, the realisation of novel interventional routes for myofibroblasts within pathologies has emerged. The research community is approaching the means to finally target these cells, to prevent fibrosis, accelerate scarless wound healing, and attenuate associated disease-processes in clinical settings. This comprehensive review article describes the myofibroblast cell phenotype, their origins, and their diverse physiological and pathological functionality. Special attention has been given to mechanisms and molecular pathways governing myofibroblast differentiation, and updates in molecular interventions.
- 23 July 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (8) , 1095
Top Cited PapersOpen AccessMyofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis
Myofibroblasts are contractile, α-smooth muscle actin-positive cells with multiple roles in pathophysiological processes. Myofibroblasts mediate wound contractions, but their persistent presence in tissues is central to driving fibrosis, making them attractive cell targets for the development of therapeutic treatments. However, due to shared cellular markers with several other phenotypes, the specific targeting of myofibroblasts has long presented a scientific and clinical challenge. In recent years, myofibroblasts have drawn much attention among scientific research communities from multiple disciplines and specialisations. As further research uncovers the characterisations of myofibroblast formation, function, and regulation, the realisation of novel interventional routes for myofibroblasts within pathologies has emerged. The research community is approaching the means to finally target these cells, to prevent fibrosis, accelerate scarless wound healing, and attenuate associated disease-processes in clinical settings. This comprehensive review article describes the myofibroblast cell phenotype, their origins, and their diverse physiological and pathological functionality. Special attention has been given to mechanisms and molecular pathways governing myofibroblast differentiation, and updates in molecular interventions.
- Open Access
- 24 August 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (9) , 1843
Hepatocyte Growth Factor Mediates Enhanced Wound Healing Responses and Resistance to Transforming Growth Factor-β1-Driven Myofibroblast Differentiation in Oral Mucosal Fibroblasts
Oral mucosal wounds are characterized by rapid healing with minimal scarring, partly attributable to the “enhanced” wound healing properties of oral mucosal fibroblasts (OMFs). Hepatocyte growth factor (HGF) is a pleiotropic growth factor, with potential key roles in accelerating healing and preventing fibrosis. HGF can exist as full-length or truncated (HGF-NK), NK1 and NK2 isoforms. As OMFs display elevated HGF expression compared to dermal fibroblasts (DFs), this study investigated the extent to which HGF mediates the preferential cellular functions of OMFs, and the influence of pro-fibrotic, transforming growth factor-β1 (TGF-β1) on these responses. Knockdown of HGF expression in OMFs by short-interfering RNA (siHGF) significantly inhibited OMF proliferative and migratory responses. Supplementation with exogenous TGF-β1 also significantly inhibited proliferation and migration, concomitant with significantly down-regulated HGF expression. In addition, knockdown abrogated OMF resistance to TGF-β1-driven myofibroblast differentiation, as evidenced by increased α-smooth muscle actin (α-SMA) expression, F-actin reorganisation, and stress fibre formation. Responses were unaffected in siHGF-transfected DFs. OMFs expressed significantly higher full-length HGF and NK1 levels compared to patient-matched DFs, whilst NK2 expression was similar in both OMFs and DFs. Furthermore, NK2 was preferentially expressed over NK1 in DFs. TGF-β1 supplementation significantly down-regulated full-length HGF and NK1 expression by OMFs, while NK2 was less affected. This study demonstrates the importance of HGF in mediating “enhanced” OMF cellular function. We also propose that full-length HGF and HGF-NK1 convey desirable wound healing properties, whilst fibroblasts preferentially expressing more HGF-NK2 readily undergo TGF-β1-driven differentiation into myofibroblasts.
- 24 August 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (9) , 1843
Open AccessHepatocyte Growth Factor Mediates Enhanced Wound Healing Responses and Resistance to Transforming Growth Factor-β1-Driven Myofibroblast Differentiation in Oral Mucosal Fibroblasts
Oral mucosal wounds are characterized by rapid healing with minimal scarring, partly attributable to the “enhanced” wound healing properties of oral mucosal fibroblasts (OMFs). Hepatocyte growth factor (HGF) is a pleiotropic growth factor, with potential key roles in accelerating healing and preventing fibrosis. HGF can exist as full-length or truncated (HGF-NK), NK1 and NK2 isoforms. As OMFs display elevated HGF expression compared to dermal fibroblasts (DFs), this study investigated the extent to which HGF mediates the preferential cellular functions of OMFs, and the influence of pro-fibrotic, transforming growth factor-β1 (TGF-β1) on these responses. Knockdown of HGF expression in OMFs by short-interfering RNA (siHGF) significantly inhibited OMF proliferative and migratory responses. Supplementation with exogenous TGF-β1 also significantly inhibited proliferation and migration, concomitant with significantly down-regulated HGF expression. In addition, knockdown abrogated OMF resistance to TGF-β1-driven myofibroblast differentiation, as evidenced by increased α-smooth muscle actin (α-SMA) expression, F-actin reorganisation, and stress fibre formation. Responses were unaffected in siHGF-transfected DFs. OMFs expressed significantly higher full-length HGF and NK1 levels compared to patient-matched DFs, whilst NK2 expression was similar in both OMFs and DFs. Furthermore, NK2 was preferentially expressed over NK1 in DFs. TGF-β1 supplementation significantly down-regulated full-length HGF and NK1 expression by OMFs, while NK2 was less affected. This study demonstrates the importance of HGF in mediating “enhanced” OMF cellular function. We also propose that full-length HGF and HGF-NK1 convey desirable wound healing properties, whilst fibroblasts preferentially expressing more HGF-NK2 readily undergo TGF-β1-driven differentiation into myofibroblasts.